Senores Pharmaceuticals Limited, a global research driven pharmaceutical company engaged in developing and manufacturing specialty, niche and complex products for Regulated and Emerging Markets, announced its unaudited financial results for the quarter ended June 30, 2026, reporting strong financial and operational performance across key business segments. The company delivered broad-based
Senores Pharmaceuticals Limited is proud to be Certified™ by Great Place To Work®. This prestigious Certification is based entirely on what current employees say about their experience working at Senores. This year, our employees said it’s a great place to work. Great Place To Work is the global authority
Senores Pharmaceuticals Limited (“SPL”), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (“SPI”), has signed agreements today to acquire a basket of 14 Abbreviated New Drug Applications (‘ANDAs’) from Dr. Reddy’s Laboratories and its applicable affiliates (BSE: 500124 | NSE: DRREDDY | NYSE: RDY |
Senores Pharmaceuticals Limited (‘Senores’ or ‘SPL’) has today inaugurated and commenced manufacturing activities at its greenfield Active Pharmaceutical Ingredient (API) plant located at Survey No. 1503, Rajpur, Kadi, Mehsana - 382 715, Gujarat. Spread across approximately 230,000 sq. ft. with an installed capacity of ~100 Metric
Senores Pharmaceuticals Limited (‘SPL’), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (‘SPI’), has signed an agreement today to acquire the USFDA-approved Abbreviated New Drug Application (‘ANDA’) for ‘Roflumilast’ 250 mcg and 500 mcg tablets from Breckenridge Pharmaceutical, Inc., a U.S. subsidiary of Towa International
Senores Pharmaceuticals Ltd. has reported revenue of ₹288 Cr during 9MFY25 ending 31st December,2024, reflecting a robust growth of 157%. The exceptional financial performance underscores the company’s strong business strategies and operational excellence. Key Highlights Total Revenue is 288 Cr which is 157% increase PAT after
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
